Neuro-laryngeal involvement in Churg-Strauss syndrome.
We report our clinical experience in managing a 59-year-old Italian male with Churg-Strauss syndrome (CSS) whose first clinical manifestation was a persistent dysphonia; the patient worked as a mechanic. Video-laryngostroboscopic examination revealed paresis of the right vocal fold with a reduction in adduction together with incomplete glottal closure. Spectrographic and spirometric tests both showed abnormal changes. Laryngeal electromyography revealed neurogenic damage of the right thyroarytenoid and crycoarytenoid muscles. Due to the appearance of typical signs of systemic involvement of CSS as a necrotizing vasculitis, the patient was admitted to the Rheumatology Unit of the University of Pisa. Histologic analysis of a skin lesion on the patient's foot confirmed the diagnosis. Treatment with 6-methylprednisolone quickly brought remission from systemic and laryngeal symptoms, as well as improvement in the results of video-laryngostroboscopic, spectrographic and laryngeal myographic tests.
Mazzantini
M
M
Department of Neuroscience, University of Pisa, Italy.
Fattori
B
B
Matteucci
F
F
Gaeta
P
P
Ursino
F
F
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015267:Churg-Strauss Syndrome / Q000150:complications* / Q000188:drug therapy; D004576:Electromyography; D005931:Glottis / Q000503:physiopathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007818:Laryngeal Diseases / Q000209:etiology; D007821:Laryngeal Muscles / Q000503:physiopathology; D007828:Laryngoscopy; D008027:Light; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use; D014741:Video Recording; D014826:Vocal Cord Paralysis / Q000209:etiology*; D014832:Voice Disorders / Q000209:etiology*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D018696:Neuroprotective Agents; D008775:Methylprednisolone